Source link : https://www.newshealth.biz/health-news/fda-approves-ponatinib-for-upfront-ph-all/
The US Food and Drug Administration has granted ponatinib (Iclusig, Takeda) accelerated approval for use with chemotherapy in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The approval makes the third-generation tyrosine kinase inhibitor (TKI) the first targeted treatment approved for upfront use in adults with Ph+ ALL, Takeda said in a […]
Author : News Health
Publish date : 2024-03-20 09:13:05
Copyright for syndicated content belongs to the linked Source.